This website is intended for UK Healthcare Professionals only.

Skip to main content
Medical Information Online
logo

OPDUALAG® (relatlimab and nivolumab) Product Information

OPDUALAG® (relatlimab and nivolumab) Product Information

Opdualag® (relatlimab/nivolumab) 240 mg/80mg concentrate for solution for infusion

Results Helpful Text
yes
no
References

You may contact our EU Data Protection Officer at EUDPO@BMS.com to exercise any data privacy rights that you may have, as well as to raise any concerns or questions in relation to the handling of your personal data by Bristol Myers Squibb Company.

Your use of this information is subject to the terms and conditions of our Legal Notice and Privacy Policy. This site is intended for healthcare partners and is for informational purposes only.

footer_logo

Bristol Myers Squibb Pharmaceuticals Limited
ARC Uxbridge Sanderson Road
New Denham, Denham Buckinghamshire
London, England UB8 1DH, GB

© 2022 Bristol Myers Squibb Company

Call BMS

Medical Information Contact Center

0800 7311 736

 

Adverse Event
or Product Quality Complaints

0800 7311 736

Privacy Policy

Cookie Preferences

Legal Notice

Site Map

Worldwide Medical Information Portal

NO-GB-2600017 05/2026